Mar 2, 2026 08:30AM

Mar 2, 2026 08:30AM

Feb 20, 2026 05:29AM

Feb 20, 2026 02:00AM

Feb 19, 2026 05:31PM

Feb 17, 2026 05:31PM

Feb 16, 2026 05:31PM Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight

Feb 4, 2026 07:48AM

Feb 3, 2026 08:02AM

Feb 3, 2026 08:00AM

Jan 16, 2026 01:43PM

Jan 16, 2026 01:43PM

Dec 22, 2025 07:06AM

Dec 2, 2025 08:15AM AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers

Nov 18, 2025 12:48PM

Nov 18, 2025 12:47PM

Nov 5, 2025 01:50PM

Oct 31, 2025 07:49AM

Oct 29, 2025 05:00PM

Oct 29, 2025 08:11AM

Oct 29, 2025 08:11AM AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo

Oct 24, 2025 08:29AM

Oct 20, 2025 08:00AM

Oct 20, 2025 08:00AM

Oct 13, 2025 10:58AM

Oct 13, 2025 10:57AM

Oct 9, 2025 08:00AM

Oct 8, 2025 12:58PM Aldeyra Therapeutics (ALDX) PT Raised to $7 at Jefferies

Oct 6, 2025 09:02AM

Oct 6, 2025 09:00AM

Oct 1, 2025 01:20PM

Oct 1, 2025 01:13PM

Sep 30, 2025 08:01AM

Sep 30, 2025 08:00AM

Sep 29, 2025 09:01AM AbbVie sets UK price for ovarian cancer drug ELAHERE equal to US rate

Sep 29, 2025 09:00AM

Sep 26, 2025 08:45AM

Sep 26, 2025 08:45AM

Sep 9, 2025 08:00AM

Sep 3, 2025 08:30AM

Sep 3, 2025 08:30AM

Aug 21, 2025 08:30AM AbbVie reports positive phase 3 trial results for alopecia areata drug

Aug 21, 2025 08:30AM

Aug 19, 2025 08:00AM

Aug 6, 2025 08:00AM

Jul 31, 2025 07:52AM

Jul 31, 2025 07:44AM

Jul 30, 2025 08:31AM

Jul 30, 2025 08:31AM AbbVie Announces Positive Topline Results from Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata

Jul 29, 2025 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All